New technologies personalize diagnostics and therapeutics

Current Atherosclerosis Reports

Volumn 12, Issue 3, 2010, Pages 184-186

  Rosenson, Robert S ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Bomarkers; Cardiovascular risk; Genomics; Lipidomics; Metabolomics; Nanotechnology; Proteomics

Indexed keywords

ATHEROSCLEROSIS; EVIDENCE BASED MEDICINE; EXPERIENCE; GENETIC RISK; GENOMICS; HIGH RISK POPULATION; HUMAN; LIFESTYLE; METABOLOMICS; MORBIDITY; MORTALITY; NANOTECHNOLOGY; PRACTICE GUIDELINE; PROTEOMICS; RECURRENT DISEASE; SHORT SURVEY; PERSONALIZED MEDICINE; PROCEDURES; PROGNOSIS; RISK FACTOR; TRENDS;

ATHEROSCLEROSIS; GENOMICS; HUMANS; INDIVIDUALIZED MEDICINE; METABOLOMICS; NANOPARTICLES; NANOTECHNOLOGY; PROGNOSIS; PROTEOMICS; RISK FACTORS;

NANOPARTICLE;

EID: 77953545297     PISSN: 15233804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11883-010-0103-x     Document Type: Short Survey

References (10)

1. Redberg RF, Benjamin EJ, Bittner V, et al.; American Academy of Family Physicians; American Association of Cardiovascular and Pulmonary Rehabilitation; Preventive Cardiovascular Nurses Association: ACCF/AHA 2009 performance measures for primary prevention of cardiovascular disease in adults: a report of the American College of Cardiology Foundation/American Heart Association task force on performance measures (writing committee to develop performance measures for primary prevention of cardiovascular disease): developed in collaboration with the American Academy of Family Physicians; American Association of Cardiovascular and Pulmonary Rehabilitation; and Preventive Cardiovascular Nurses Association: endorsed by the American College of Preventive Medicine, American College of Sports Medicine, and Society for Women's Health Research. Circulation 2009, 120:1296-1336.
2. Anderson JL, Adams CD, Antman EM, et al.: ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/ Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol 2007, 50:e1-e157.
3. Seo D, Goldschmidt-Clermont P, Velazquez O, Beecham G: Genomics of premature atherosclerotic vascular disease. Curr Atherocler Rep 2010 (in press).
4. Martinez-Pinna R, Barbas C, Blanco-Colio LM, et al.: Proteomic and metabolomic profiles in atherothrombotic vascular disease. Curr Atheroscler Rep 2010 (in press).
5. Goonewardena SN, Prevette LE, Desai AA: Metabolomics and atherosclerosis. Curr Atheroscler Rep 2010 (in press).
6. Ekroos K, Janis M, Tarsasov K, et al.: Lipidomics: a tool for studies on atherosclerosis. Curr Atheroscler Rep 2010 (in press).
7. Kontush A, Chapman J: Lipidomics as a tool for study of lipoprotein metabolism. Curr Atheroscler Rep 2010 (in press).
8. 2 inhibitors in the prevention of atherosclerotic cardiovascular disease. Cardiovasc Drugs Ther 2009, 23:93-101.
9. Rosenson RS: Functional aspects of HDL: moving beyond static measures for risk assessment. Cardiovac Drugs Ther 2010 (in press).
10. Jayagopal A, Linton MF, Fazio S, Haselton FR: Insights into atherosclerosis using nanotechnology. Curr Atheroscler Rep 2010 (in press).